Industry Strength Score
16/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
SHARPS TECHNOLOGY INC (STSS) Stock Price & Overview
NASDAQ:STSS • US82003F3091
Current stock price
1.78 USD
-0.01 (-0.56%)
Last:
The current stock price of STSS is 1.78 USD. Today STSS is down by -0.56%. In the past month the price increased by 14.74%. In the past year, price decreased by -62.32%.
STSS Key Statistics
52-Week Range1.415 - 18.23
Current STSS stock price positioned within its 52-week range.
1-Month Range1.42 - 1.97
Current STSS stock price positioned within its 1-month range.
- Market Cap
- 68.815M
- P/E
- 0.05
- Fwd P/E
- N/A
- EPS (TTM)
- 35.49
- Dividend Yield
- N/A
STSS Stock Performance
Today
-0.56%
1 Week
-2.19%
1 Month
+14.74%
3 Months
-13.53%
Longer-term
6 Months -59.41%
1 Year -62.32%
2 Years -99.90%
3 Years -99.97%
5 Years N/A
10 Years N/A
STSS Stock Chart
STSS Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to STSS. When comparing the yearly performance of all stocks, STSS is a bad performer in the overall market: 92.56% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
STSS Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to STSS. STSS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
STSS Earnings
Next Earnings DateN/A
Last Earnings DateMar 31, 2026
PeriodQ4 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise -99.56%
STSS Forecast & Estimates
7 analysts have analysed STSS and the average price target is 22.44 USD. This implies a price increase of 1160.67% is expected in the next year compared to the current price of 1.78.
Analysts
Analysts82.86
Price Target22.44 (1160.67%)
EPS Next YN/A
Revenue Next YearN/A
STSS Financial Highlights
Over the last trailing twelve months STSS reported a non-GAAP Earnings per Share(EPS) of 35.49. The EPS increased by 101.69% compared to the year before.
Income Statements
Revenue(TTM)7.01M
Net Income(TTM)-282.50M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -104.99% | ||
| ROE | -106.85% | ||
| Debt/Equity | 0.01 |
Chartmill High Growth Momentum
EPS Q2Q%99.67%
Sales Q2Q%N/A
EPS 1Y (TTM)101.69%
Revenue 1Y (TTM)N/A
STSS Ownership
Ownership
Inst Owners27.14%
Shares38.66M
Float36.52M
Ins Owners0.09%
Short Float %1.71%
Short Ratio1.85
STSS Industry Overview
STSS operates in the Health Care Supplies sub-industry within the Health Care sector. This group contains 34 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Growth Score
33/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
22%
Outperformed 22% of sub-industries
3 Month Rank
14%
Outperformed 14% of sub-industries
6 Month Rank
25%
Outperformed 25% of sub-industries
Industry Fundamentals & Breadth
- Members
- 34
- New Highs
- 2.9%
- New Lows
- 8.8%
- Average ROE
- 12.6%
- Average Profit Margin
- 7.9%
- Average Operating Margin
- 10.8%
- Average P/E
- 24.3
- Average Fwd P/E
- 21.2
- Average Debt/Equity
- 0.9
STSS Competitors/Peers
The largest stocks on the US markets in the "Health Care Supplies" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| MDLN | MEDLINE INC-CL A | 29.09 | 58.118B | ||
| ALGN | ALIGN TECHNOLOGY INC | 15.43 | 12.697B | ||
| COO | COOPER COS INC/THE | 12.28 | 12.31B | ||
| SOLV | SOLVENTUM CORP | 10.16 | 11.707B | ||
| LNTH | LANTHEUS HOLDINGS INC | 15.37 | 5.428B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 15.74 | 3.981B | ||
| ICUI | ICU MEDICAL INC | 14.04 | 3.024B | ||
| HAE | HAEMONETICS CORP/MASS | 11.14 | 2.781B | ||
| XRAY | DENTSPLY SIRONA INC | 7.84 | 2.353B | ||
| NEOG | NEOGEN CORP | 26.79 | 2.033B | ||
| UFPT | UFP TECHNOLOGIES INC | 18.94 | 1.505B | ||
| STAA | STAAR SURGICAL CO | N/A | 1.322B | ||
| AVNS | AVANOS MEDICAL INC | 24.12 | 1.146B |
Related stock screener links
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About STSS
Company Profile
Sharps Technology, Inc. is a medical device and pharmaceutical packaging company, which engages in the development and manufacturing of innovative drug delivery systems. The company is headquartered in Melville, New York and currently employs 5 full-time employees. The company went IPO on 2022-04-14. The firm is engaged in offering patented smart-safety syringe products to the healthcare industry. The firm's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. The company Sharps Securegard and Sologard safety syringe product lines incorporate both active and passive safety features and have been designed to address the primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. The company also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. The company has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.
Company Info
IPO: 2022-04-14
SHARPS TECHNOLOGY INC
105 Maxess Road, Ste. 124
Melville NEW YORK US
Employees: 5
Phone: 15162464000
SHARPS TECHNOLOGY INC / STSS FAQ
What does STSS do?
Sharps Technology, Inc. is a medical device and pharmaceutical packaging company, which engages in the development and manufacturing of innovative drug delivery systems. The company is headquartered in Melville, New York and currently employs 5 full-time employees. The company went IPO on 2022-04-14. The firm is engaged in offering patented smart-safety syringe products to the healthcare industry. The firm's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. The company Sharps Securegard and Sologard safety syringe product lines incorporate both active and passive safety features and have been designed to address the primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. The company also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. The company has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.
What is the stock price of SHARPS TECHNOLOGY INC today?
The current stock price of STSS is 1.78 USD. The price decreased by -0.56% in the last trading session.
Does SHARPS TECHNOLOGY INC pay dividends?
STSS does not pay a dividend.
What is the ChartMill technical and fundamental rating of STSS stock?
STSS has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Which stock exchange lists STSS stock?
STSS stock is listed on the Nasdaq exchange.
Can you provide the short interest for STSS stock?
The outstanding short interest for SHARPS TECHNOLOGY INC (STSS) is 1.71% of its float.